13D/13G Filings - MURPHY JOHN RAYMOND

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-01-15
4:23 pm
Purchase
2024-12-3113GCadrenal Therapeutics, Inc. Common Stock
CVKD
MURPHY JOHN RAYMOND53,205
2.960%
53,205increase
(New Position)
Filing
History
2024-02-13
5:18 pm
Purchase
2023-12-3113GCadrenal Therapeutics, Inc. Common Stock
CVKD
MURPHY JOHN RAYMOND47,653
5.490%
8,000increase
(+20.18%)
Filing
History
2023-03-27
06:09 am
Purchase
2023-03-1613GCadrenal Therapeutics, Inc. Common Stock
CVKD
MURPHY JOHN RAYMOND39,653
5.110%
39,653increase
(New Position)
Filing
History